GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (MIL:1AFX) » Definitions » Cyclically Adjusted PS Ratio

Carl Zeiss Meditec AG (MIL:1AFX) Cyclically Adjusted PS Ratio : 4.73 (As of May. 25, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Carl Zeiss Meditec AG Cyclically Adjusted PS Ratio?

As of today (2024-05-25), Carl Zeiss Meditec AG's current share price is €92.85. Carl Zeiss Meditec AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €19.65. Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio for today is 4.73.

The historical rank and industry rank for Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio or its related term are showing as below:

MIL:1AFX' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 4.06   Med: 7.11   Max: 13.68
Current: 5.02

During the past years, Carl Zeiss Meditec AG's highest Cyclically Adjusted PS Ratio was 13.68. The lowest was 4.06. And the median was 7.11.

MIL:1AFX's Cyclically Adjusted PS Ratio is ranked worse than
70.82% of 473 companies
in the Medical Devices & Instruments industry
Industry Median: 2.26 vs MIL:1AFX: 5.02

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Carl Zeiss Meditec AG's adjusted revenue per share data for the three months ended in Mar. 2024 was €5.282. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €19.65 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Carl Zeiss Meditec AG Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG Cyclically Adjusted PS Ratio Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.11 8.05 11.40 6.14 4.47

Carl Zeiss Meditec AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.22 5.47 4.47 5.29 6.09

Competitive Comparison of Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio falls into.



Carl Zeiss Meditec AG Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=92.85/19.65
=4.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carl Zeiss Meditec AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Carl Zeiss Meditec AG's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.282/125.0381*125.0381
=5.282

Current CPI (Mar. 2024) = 125.0381.

Carl Zeiss Meditec AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 2.602 99.543 3.268
201409 2.857 99.823 3.579
201412 3.026 99.543 3.801
201503 3.064 99.717 3.842
201506 3.044 100.417 3.790
201509 3.638 100.417 4.530
201512 3.302 99.717 4.140
201603 3.404 100.017 4.256
201606 3.128 100.717 3.883
201609 3.614 101.017 4.473
201612 3.443 101.217 4.253
201703 3.763 101.417 4.639
201706 3.120 102.117 3.820
201709 3.610 102.717 4.394
201712 3.309 102.617 4.032
201803 3.586 102.917 4.357
201806 3.505 104.017 4.213
201809 3.909 104.718 4.668
201812 3.608 104.217 4.329
201903 3.857 104.217 4.628
201906 4.046 105.718 4.785
201909 4.798 106.018 5.659
201912 4.097 105.818 4.841
202003 3.853 105.718 4.557
202006 2.824 106.618 3.312
202009 4.170 105.818 4.927
202012 4.143 105.518 4.909
202103 4.475 107.518 5.204
202106 4.880 108.486 5.625
202109 4.994 109.435 5.706
202112 4.546 110.384 5.150
202203 4.956 113.968 5.437
202206 5.345 115.760 5.773
202209 6.352 118.818 6.685
202212 5.256 119.345 5.507
202303 5.611 122.402 5.732
202306 5.987 123.140 6.079
202309 6.518 124.195 6.562
202312 5.334 123.773 5.389
202403 5.282 125.038 5.282

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Carl Zeiss Meditec AG  (MIL:1AFX) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Carl Zeiss Meditec AG Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Carl Zeiss Meditec AG (MIL:1AFX) Business Description

Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

Carl Zeiss Meditec AG (MIL:1AFX) Headlines

No Headlines